Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Harmony Biosciences Holdings, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 57 | 84 | +27 |
| Shares | 27.5M | 28.0M | +525.7K (+1.9%) |
| Value | $907.6M | $790.3M | −$117.3M (−12.9%) |
New holders (33)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (6)
Institutions that held Harmony Biosciences Holdings, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Logos Global Management LP | 100,000 | $3.30M |
| Arrowstreet Capital, Limited Partnership | 17,134 | $566.0K |
| Marshall Wace, LLP | 15,545 | $514.0K |
| Susquehanna International Group, LLP | 13,801 | $456.0K |
| California Public Employees Retirement System | 11,000 | $363.0K |
| Bank of Montreal | 190 | $5.00K |